Your Health, We Care
Release date: 2024-08-28 14:37:50 Recommended: 119
Balversa is an oral anti-tumor drug for the treatment of urothelial carcinoma with FGFR2/3 mutations, which blocks tumor growth by inhibiting FGFR activity, but it is necessary to pay attention to visual side effects.
Balversa may interact with a variety of drugs during use, and the two main interactions are listed below:
Gastric acid inhibitors such as omeprazole may reduce the solubility of Balversa by raising the pH in the stomach, thereby affecting the absorption of the drug and leading to a weakened efficacy of the drug. When using both drugs at the same time, it is important to pay attention to the time interval of the drug to avoid the occurrence of interactions.
Balversa is a substrate and inhibitor of CYP3A4, and interaction with CYP3A4 may affect the metabolism and excretion of Balversa. Special care should be taken to avoid concomitant use with CYP3A4 inducers or inhibitors or to adjust the regimen under the guidance of a physician.
When discussing the safety of Balversa, it is necessary to be vigilant about its interaction with other drugs. Especially when used with gastric acid suppressants, it may affect the absorption of the drug, so it is recommended to adjust the time or dosage of the drug and consult a doctor.
The following two points can be considered for the response to the interaction of Balversa with gastric acid suppressants:
Try to stagger the timing of Balversa and gastric acid suppressants to reduce direct interactions between the two in the gastrointestinal tract. This ensures that Balversa is absorbed when stomach acid levels are low, increasing its bioavailability.
During the combination of Balversa and gastric acid suppressants, patients are closely monitored for treatment efficacy and drug side effects. If it is found that the efficacy of Balversa is weakened or new adverse reactions occur, you should communicate with your doctor in time to adjust the treatment plan or take other remedial measures.
For the interaction of Balversa with gastric acid suppressants, patients should adjust their medication according to their doctor's instructions. It is also necessary to monitor liver function and avoid high-risk activities such as driving to ensure that the treatment is safe and effective.
Daily precautions for Balversa include:
Balversa may have an impact on liver function, and patients should have regular liver function tests, such as liver enzyme level monitoring, during treatment to detect and manage possible liver function abnormalities in a timely manner.
Some patients may have visual problems such as blurred vision and light sensitivity after taking Balversa. Patients should pay close attention to their visual changes and inform their doctor if there is any abnormality so that appropriate measures can be taken.
【Warm tips】When patients buy generic drugs, they should choose formal channels to ensure the quality and safety of the drugs. Avoid purchasing counterfeit products from informal sources.
